CLPT Financial Statements

Balance sheet, income statement, cash flow, and dividends for Clearpoint Neuro Inc (CLPT).


$424.25M Market Cap.

As of 02/26/2025 5:00 PM ET (MRY) • Disclaimer

CLPT Market Cap. (MRY)


CLPT Shares Outstanding (MRY)


CLPT Assets (MRY)


Total Assets

$39.19M

Total Liabilities

$13.80M

Total Investments

$0

CLPT Income (MRY)


Revenue

$31.39M

Net Income

-$18.91M

Operating Expense

$38.87M

CLPT Cash Flow (MRY)


CF Operations

-$8.95M

CF Investing

-$275.00K

CF Financing

$6.19M

CLPT Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

CLPT Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$39,189,000 (-8.14%)

$42,661,000 (-23.12%)

$55,490,000 (-15.39%)

$65,581,000 (122.17%)

Assets Current

$33,363,000 (-7.77%)

$36,172,000 (-29.32%)

$51,180,000 (-17.31%)

$61,892,000 (143.08%)

Assets Non-Current

$5,826,000 (-10.22%)

$6,489,000 (50.56%)

$4,310,000 (16.83%)

$3,689,000 (-9.05%)

Goodwill & Intangible Assets

$587,000 (-58.86%)

$1,427,000 (-3.45%)

$1,478,000 (88.52%)

$784,000 (-16.77%)

Shareholders Equity

$25,389,000 (19.91%)

$21,173,000 (-42.60%)

$36,887,000 (-24.39%)

$48,787,000 (1952.46%)

Property Plant & Equipment Net

$5,091,000 (2.79%)

$4,953,000 (83.38%)

$2,701,000 (-2.84%)

$2,780,000 (-9.00%)

Cash & Equivalents

$20,104,000 (-13.12%)

$23,140,000 (-16.20%)

$27,615,000 (-48.96%)

$54,109,000 (169.21%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$2,557,000 (-18.93%)

$3,154,000 (116.62%)

$1,456,000 (54.56%)

$942,000 (21.24%)

Total Investments

$0 (0%)

$0 (0%)

$9,874,000 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$9,874,000 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$6,863,000 (-13.25%)

$7,911,000 (-14.96%)

$9,303,000 (88.40%)

$4,938,000 (52.50%)

Trade & Non-Trade Receivables

$4,713,000 (46.78%)

$3,211,000 (20.49%)

$2,665,000 (14.04%)

$2,337,000 (24.24%)

Trade & Non-Trade Payables

$1,340,000 (240.97%)

$393,000 (44.49%)

$272,000 (-36.30%)

$427,000 (42.33%)

Accumulated Retained Earnings (Deficit)

-$191,370,000 (-10.97%)

-$172,456,000 (-14.69%)

-$150,367,000 (-12.27%)

-$133,932,000 (-12.06%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$3,568,000 (-74.41%)

$13,941,000 (16.31%)

$11,986,000 (-2.43%)

$12,284,000 (-49.07%)

Debt Current

$557,000 (31.37%)

$424,000 (-24.42%)

$561,000 (10.65%)

$507,000 (28.68%)

Debt Non-Current

$3,011,000 (-77.72%)

$13,517,000 (18.31%)

$11,425,000 (-2.99%)

$11,777,000 (-50.36%)

Total Liabilities

$13,800,000 (-35.78%)

$21,488,000 (15.51%)

$18,603,000 (10.77%)

$16,794,000 (-38.12%)

Liabilities Current

$10,353,000 (39.34%)

$7,430,000 (9.46%)

$6,788,000 (42.82%)

$4,753,000 (48.53%)

Liabilities Non-Current

$3,447,000 (-75.48%)

$14,058,000 (18.98%)

$11,815,000 (-1.88%)

$12,041,000 (-49.71%)

CLPT Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$31,390,000 (31.04%)

$23,955,000 (16.56%)

$20,551,000 (26.09%)

$16,299,000 (27.05%)

Cost of Revenue

$12,268,000 (18.63%)

$10,341,000 (47.31%)

$7,020,000 (35.63%)

$5,176,000 (39.55%)

Selling General & Administrative Expense

$26,476,000 (8.73%)

$24,351,000 (28.37%)

$18,969,000 (24.66%)

$15,216,000 (42.82%)

Research & Development Expense

$12,392,000 (5.83%)

$11,709,000 (7.48%)

$10,894,000 (17.38%)

$9,281,000 (98.06%)

Operating Expenses

$38,868,000 (7.79%)

$36,060,000 (20.75%)

$29,863,000 (21.90%)

$24,497,000 (59.69%)

Interest Expense

$0 (0%)

-$386,000 (-576.54%)

$81,000 (-91.68%)

$973,000 (-32.62%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$18,914,000 (14.37%)

-$22,089,000 (-34.40%)

-$16,435,000 (-14.05%)

-$14,410,000 (-112.47%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$18,914,000 (14.37%)

-$22,089,000 (-34.40%)

-$16,435,000 (-14.05%)

-$14,410,000 (-112.47%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$18,914,000 (14.37%)

-$22,089,000 (-34.40%)

-$16,435,000 (-14.05%)

-$14,410,000 (-112.47%)

Weighted Average Shares

$27,027,692 (9.85%)

$24,605,212 (1.75%)

$24,181,854 (16.63%)

$20,734,236 (30.82%)

Weighted Average Shares Diluted

$27,027,692 (9.85%)

$24,605,212 (1.75%)

$24,181,854 (16.63%)

$20,734,236 (30.82%)

Earning Before Interest & Taxes (EBIT)

-$18,914,000 (15.84%)

-$22,475,000 (-37.43%)

-$16,354,000 (-21.71%)

-$13,437,000 (-151.72%)

Gross Profit

$19,122,000 (40.46%)

$13,614,000 (0.61%)

$13,531,000 (21.65%)

$11,123,000 (21.96%)

Operating Income

-$19,746,000 (12.03%)

-$22,446,000 (-37.44%)

-$16,332,000 (-22.12%)

-$13,374,000 (-115.02%)

CLPT Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$275,000 (-103.07%)

$8,949,000 (183.36%)

-$10,736,000 (-6290.48%)

-$168,000 (65.15%)

Net Cash Flow from Financing

$6,189,000 (1990.88%)

$296,000 (-27.63%)

$409,000 (-99.13%)

$46,875,000 (106.57%)

Net Cash Flow from Operations

-$8,950,000 (34.77%)

-$13,720,000 (15.14%)

-$16,167,000 (-27.33%)

-$12,697,000 (-62.64%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$3,036,000 (32.16%)

-$4,475,000 (83.11%)

-$26,494,000 (-177.90%)

$34,010,000 (136.13%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$10,000,000 (204.28%)

-$9,590,000 (0%)

$0 (0%)

Capital Expenditure

-$275,000 (73.83%)

-$1,051,000 (8.29%)

-$1,146,000 (-582.14%)

-$168,000 (65.15%)

Issuance (Repayment) of Debt Securities

-$10,000,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$16,613,000 (3183.20%)

$506,000 (-32.08%)

$745,000 (-98.43%)

$47,474,000 (12526.06%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$6,907,000 (13.62%)

$6,079,000 (47.33%)

$4,126,000 (98.56%)

$2,078,000 (90.64%)

Depreciation Amortization & Accretion

$1,903,000 (30.61%)

$1,457,000 (87.52%)

$777,000 (12.28%)

$692,000 (25.82%)

CLPT Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

60.90% (7.22%)

56.80% (-13.68%)

65.80% (-3.52%)

68.20% (-4.08%)

Profit Margin

-60.30% (34.60%)

-92.20% (-15.25%)

-80.00% (9.50%)

-88.40% (-67.11%)

EBITDA Margin

-54.20% (38.20%)

-87.70% (-15.70%)

-75.80% (3.07%)

-78.20% (-109.65%)

Return on Average Equity (ROAE)

-62.50% (25.51%)

-83.90% (-110.80%)

-39.80% (-27.56%)

-31.20% (92.38%)

Return on Average Assets (ROAA)

-40.80% (14.82%)

-47.90% (-71.68%)

-27.90% (-36.10%)

-20.50% (25.99%)

Return on Sales (ROS)

-60.30% (35.71%)

-93.80% (-17.84%)

-79.60% (3.40%)

-82.40% (-98.08%)

Return on Invested Capital (ROIC)

-131.80% (-63.93%)

-80.40% (-68.55%)

-47.70% (9.14%)

-52.50% (-118.75%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-21.97 (-191.24%)

-7.54 (39.43%)

-12.46 (23.40%)

-16.26 (56.00%)

Price to Sales Ratio (P/S)

13.24 (89.89%)

6.97 (-30.02%)

9.97 (-30.18%)

14.27 (-27.29%)

Price to Book Ratio (P/B)

16.71 (111.63%)

7.9 (40.05%)

5.64 (3.70%)

5.44 (-95.18%)

Debt to Equity Ratio (D/E)

0.54 (-46.40%)

1.01 (101.39%)

0.5 (46.51%)

0.34 (-96.99%)

Earnings Per Share (EPS)

-0.7 (22.22%)

-0.9 (-32.35%)

-0.68 (1.45%)

-0.69 (-60.47%)

Sales Per Share (SPS)

1.16 (19.20%)

0.97 (14.59%)

0.85 (8.14%)

0.79 (-2.84%)

Free Cash Flow Per Share (FCFPS)

-0.34 (43.17%)

-0.6 (16.20%)

-0.72 (-15.48%)

-0.62 (-18.55%)

Book Value Per Share (BVPS)

0.94 (9.06%)

0.86 (-43.54%)

1.52 (-35.19%)

2.35 (1468.67%)

Tangible Assets Book Value Per Share (TABVPS)

1.43 (-14.80%)

1.68 (-24.98%)

2.23 (-28.51%)

3.13 (73.32%)

Enterprise Value Over EBIT (EV/EBIT)

-21 (-200.00%)

-7 (41.67%)

-12 (29.41%)

-17 (66.67%)

Enterprise Value Over EBITDA (EV/EBITDA)

-23.89 (-220.14%)

-7.46 (42.24%)

-12.92 (27.71%)

-17.87 (68.48%)

Asset Turnover

0.68 (30.19%)

0.52 (49.00%)

0.35 (50.43%)

0.23 (-55.73%)

Current Ratio

3.22 (-33.79%)

4.87 (-35.44%)

7.54 (-42.10%)

13.02 (63.65%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$9,225,000 (37.55%)

-$14,771,000 (14.68%)

-$17,313,000 (-34.57%)

-$12,865,000 (-55.21%)

Enterprise Value (EV)

$406,373,671 (159.09%)

$156,845,650 (-22.05%)

$201,216,098 (-11.65%)

$227,755,492 (-16.10%)

Earnings Before Tax (EBT)

-$18,914,000 (14.37%)

-$22,089,000 (-34.40%)

-$16,435,000 (-14.05%)

-$14,410,000 (-112.47%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$17,011,000 (19.06%)

-$21,018,000 (-34.93%)

-$15,577,000 (-22.22%)

-$12,745,000 (-166.19%)

Invested Capital

$11,713,000 (-52.40%)

$24,605,000 (-22.12%)

$31,595,000 (73.42%)

$18,219,000 (-38.02%)

Working Capital

$23,010,000 (-19.94%)

$28,742,000 (-35.25%)

$44,392,000 (-22.31%)

$57,139,000 (156.67%)

Tangible Asset Value

$38,602,000 (-6.38%)

$41,234,000 (-23.66%)

$54,012,000 (-16.64%)

$64,797,000 (126.75%)

Market Capitalization

$424,252,671 (153.78%)

$167,173,650 (-19.62%)

$207,977,098 (-21.59%)

$265,236,492 (-1.05%)

Average Equity

$30,276,500 (15.06%)

$26,314,250 (-36.33%)

$41,328,750 (-10.57%)

$46,213,750 (2689.93%)

Average Assets

$46,398,250 (0.65%)

$46,096,500 (-21.62%)

$58,809,000 (-16.25%)

$70,218,000 (186.65%)

Invested Capital Average

$14,350,750 (-48.65%)

$27,945,500 (-18.47%)

$34,274,500 (33.83%)

$25,610,000 (14.92%)

Shares

27,584,699 (12.04%)

24,620,567 (0.27%)

24,554,557 (3.87%)

23,639,616 (40.13%)